(Q70860091)
Statements
Percentage of anti-CD4 monoclonal antibody-coated lymphocytes in the rheumatoid joint is associated with clinical improvement. Implications for the development of immunotherapeutic dosing regimens (English)
E H Choy
C Pitzalis
A Cauli
J A Bijl
A Schantz
J Woody
G H Kingsley
1 January 1996